Coronary revascularization in patients with stable coronary artery disease is underused in those who are considered candidates for the procedure, resulting in worse outcomes than among those who are treated invasively according to appropriate use criteria. Researchers reported in the Journal of the American College of Cardiology that in cases where criteria were followed, revascularization reduced the three-year risk of death or recurrent ACS. Although the study suggested some patients being treated invasively did not meet criteria, "there are also patients who would benefit from revascularization and are not getting it," said lead author Dr. Dennis Ko.

Related Summaries